Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors
- 1 April 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 150, 30-38
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81630093, 81473107)
- Shandong Province (2015ZDJS04001)
- Shandong Province (2017CXGC1403)
This publication has 26 references indexed in Scilit:
- Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2013
- Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivativesEuropean Journal of Medicinal Chemistry, 2012
- Synthesis and Molecular Modeling of Novel Tetrahydro-β-carboline Derivatives with Phosphodiesterase 5 Inhibitory and Anticancer PropertiesJournal of Medicinal Chemistry, 2010
- PDE5 inhibitors beyond erectile dysfunctionInternational Journal Of Impotence Research, 2007
- Pyrroloquinolone PDE5 Inhibitors with Improved Pharmaceutical Profiles for Clinical Studies on Erectile DysfunctionJournal of Medicinal Chemistry, 2004
- A Revised Structure for the Alkaloid, Tribulusterine, from Tribulus terrestris L.Australian Journal of Chemistry, 2004
- Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 InhibitorsJournal of Medicinal Chemistry, 2003
- Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- A Fluorescence Polarization Assay for Cyclic Nucleotide PhosphodiesterasesSLAS Discovery, 2002
- The Chemical Development of the Commercial Route to Sildenafil: A Case HistoryOrganic Process Research & Development, 1999